Market Cap 22.07M
Revenue (ttm) 0.00
Net Income (ttm) -12.20M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.22
Volume 303,400
Avg Vol 12,813,074
Day's Range N/A - N/A
Shares Out 7.61M
Stochastic %K 66%
Beta 1.41
Analysts Strong Buy
Price Target $17.00

Company Profile

Tharimmune, Inc., a clinical-stage biotechnology company, engages in the development of therapeutic candidates for rare, inflammatory, and oncologic conditions with high unmet need in the United States. The company's pre-clinical immuno-oncology pipeline includes TH104, a product candidate for the treatment of liver-related and other pruritogenic inflammatory conditions; TH023 which is phase 1 clinical trial used to treat multiple high value autoimmune indications; and HS1940, which targets prog...

Industry: Biotechnology
Sector: Healthcare
Phone: 908 270 8260
Address:
1200 Route 22 East, Suite 2000, Bridgewater, United States
WIRE143
WIRE143 Oct. 23 at 7:58 PM
$THAR TH104 as a prophylactic countermeasure for first responders exposed to high-potency opioids has a potential domestic TAM of around $100M if you factor in approximately 2 million US first responders/military personnel x 40/50 a pill, that doesn’t factor in government stock piling. Also Factor in 5 million EU/UK military/first responders, and we have 7 million potential patients and around 300-350m global TAM which excludes Asia. Company only has a 20m market cap and a tiny float of 2m+ shares. FDA allowed company to pursue NDA without any more trials.
0 · Reply
BillionerOfKing
BillionerOfKing Oct. 23 at 6:17 PM
$THAR Current Stock Price: $2.82 No options data available.
0 · Reply
Watchbanker
Watchbanker Oct. 21 at 4:14 PM
$THAR Trend Analysis THAR appears to be in a strong bullish trend. Its 200-day moving average is upwards sloping and the MACD histogram is above 0 and rising. Comparative Relative Strength analysis shows that this issue is lagging the S&P 500. As of 11:57 AM ET Tuesday, 10/21/2025
0 · Reply
Makingmillions192
Makingmillions192 Oct. 21 at 2:58 PM
$LEXX Next $THAR type of move coming
0 · Reply
Watchbanker
Watchbanker Oct. 14 at 4:07 PM
$THAR Only way up...No one is selling
0 · Reply
Makingmillions192
Makingmillions192 Oct. 13 at 8:08 PM
$LEXX Also just for reference - after $THAR reported successful phase one results the stock ran like 600%. So lock in before we report phase 1b in Nov / Dec…. 💰
0 · Reply
Ian980
Ian980 Oct. 10 at 7:23 PM
$THAR trumps threatening china on new tariffs crashed everything
1 · Reply
nerowinger
nerowinger Oct. 10 at 6:39 PM
$THAR whole market crashing
0 · Reply
Nye321
Nye321 Oct. 10 at 4:44 PM
$THAR I’m in I feel like we may have another run
0 · Reply
daytraderkns
daytraderkns Oct. 10 at 2:51 PM
$THAR someone explain …. Bought this on a whim got too deep
2 · Reply
Latest News on THAR
Tharimmune to Present at the Microcap Conference 2025

Jan 27, 2025, 8:30 AM EST - 9 months ago

Tharimmune to Present at the Microcap Conference 2025


Tharimmune Announces Upcoming Conference Presentations

Nov 4, 2024, 9:00 AM EST - 1 year ago

Tharimmune Announces Upcoming Conference Presentations


Tharimmune Announces 1-for-25 Reverse Stock Split

Nov 17, 2023, 7:00 AM EST - 2 years ago

Tharimmune Announces 1-for-25 Reverse Stock Split


WIRE143
WIRE143 Oct. 23 at 7:58 PM
$THAR TH104 as a prophylactic countermeasure for first responders exposed to high-potency opioids has a potential domestic TAM of around $100M if you factor in approximately 2 million US first responders/military personnel x 40/50 a pill, that doesn’t factor in government stock piling. Also Factor in 5 million EU/UK military/first responders, and we have 7 million potential patients and around 300-350m global TAM which excludes Asia. Company only has a 20m market cap and a tiny float of 2m+ shares. FDA allowed company to pursue NDA without any more trials.
0 · Reply
BillionerOfKing
BillionerOfKing Oct. 23 at 6:17 PM
$THAR Current Stock Price: $2.82 No options data available.
0 · Reply
Watchbanker
Watchbanker Oct. 21 at 4:14 PM
$THAR Trend Analysis THAR appears to be in a strong bullish trend. Its 200-day moving average is upwards sloping and the MACD histogram is above 0 and rising. Comparative Relative Strength analysis shows that this issue is lagging the S&P 500. As of 11:57 AM ET Tuesday, 10/21/2025
0 · Reply
Makingmillions192
Makingmillions192 Oct. 21 at 2:58 PM
$LEXX Next $THAR type of move coming
0 · Reply
Watchbanker
Watchbanker Oct. 14 at 4:07 PM
$THAR Only way up...No one is selling
0 · Reply
Makingmillions192
Makingmillions192 Oct. 13 at 8:08 PM
$LEXX Also just for reference - after $THAR reported successful phase one results the stock ran like 600%. So lock in before we report phase 1b in Nov / Dec…. 💰
0 · Reply
Ian980
Ian980 Oct. 10 at 7:23 PM
$THAR trumps threatening china on new tariffs crashed everything
1 · Reply
nerowinger
nerowinger Oct. 10 at 6:39 PM
$THAR whole market crashing
0 · Reply
Nye321
Nye321 Oct. 10 at 4:44 PM
$THAR I’m in I feel like we may have another run
0 · Reply
daytraderkns
daytraderkns Oct. 10 at 2:51 PM
$THAR someone explain …. Bought this on a whim got too deep
2 · Reply
Baazigar30
Baazigar30 Oct. 8 at 10:28 PM
$THAR I m here so far ..💰💰
1 · Reply
nerowinger
nerowinger Oct. 8 at 7:43 PM
$THAR $INDP $YAAS $PBM money here..
0 · Reply
nerowinger
nerowinger Oct. 8 at 2:32 PM
$THAR need volume here still hold
0 · Reply
Drugtrade
Drugtrade Oct. 8 at 2:29 PM
$THAR adding few on dips.. will they let it stay over $3?
0 · Reply
daytraderkns
daytraderkns Oct. 8 at 1:53 PM
$THAR I’m so deep in this I think this little run is where I take my money
0 · Reply
Watchbanker
Watchbanker Oct. 8 at 1:47 PM
0 · Reply
nerowinger
nerowinger Oct. 8 at 1:44 PM
$THAR added
0 · Reply
x1fisher
x1fisher Oct. 8 at 11:10 AM
QTTB most undervalued biotech play on the market. $15 Price target by wells fargo Cash runaway into 2027 with upcoming Phase 2 trial data No warrants and a low float with shorts fully trapped. The squeeze will be historic. $GLTO $XBIO $PHIO $THAR $BURU ww
0 · Reply
Xvool
Xvool Oct. 6 at 6:29 PM
$THAR $3.01 Flagging watch for the break 👁️ also $SPRB $SOPA
0 · Reply
Sw1ngb0t
Sw1ngb0t Oct. 3 at 8:17 PM
1 · Reply
Sw1ngb0t
Sw1ngb0t Oct. 2 at 9:13 PM
1 · Reply
x1fisher
x1fisher Oct. 2 at 6:41 PM
MYSE stock new app launch any day now, low float squeeze potential with shorts trapped. Ran to $10 earlier in the year and the CEO IS LOADING $OPEN $MRM $THAR $AMC $GME ww
0 · Reply